EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding

Hiroyuki Hiratsuka, Yasushi Akahori, Shingo Maeta, Yuriko Egashira, Hiroshi Shiku

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Hiroyuki Hiratsuka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Personalized Cancer Immunotherapy, Graduate School of Medicine, Mie University, Tsu, Mie, Japan. Electronic address: 318ds09@m.mie-u.ac…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Antigens, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sysmex Corp, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) is a synthetic receptor that induces T cell-mediated lysis of abnormal cells. As cancer driver proteins are present at low levels on the cell surface, they can cause weak CAR reactivity, resulting in antigen sensitivity defects and consequently limited therapeutic efficacy. Although affinity maturation enhances the efficacy of CAR-T cell therapy, it causes off-target cross-reactions resulting in adverse effects. Preferentially expressed antigen in melanoma (PRAME) is an intracellular oncoprotein that is overexpressed in various tumors and restricted in normal tissues, except the testis. Therefore, PRAME could be an ideal target for cancer immunotherapy. In this study, we developed an experimental CAR system comprising six single-chain variable fragments that specifically recognizes the PRAMEp301/HLA-A∗24:02 complex. Cell-mediated cytotoxicity was demonstrated using a panel of CARs with a wide range of affinities (KD = 10-10-10-7 M) and affinity modulation. CAR-T cells with fast on-rates enhance antigen sensitivity by accelerating the killing rates of these cells. Alanine scanning data demonstrated the potential of genetically engineered CARs to reduce the risk of cross-reactivity, even among CARs with high affinities. Given the correlation between on-rates and dwell time that occurs in rebinding and cell-mediated cytotoxicity, it is proposed that CAR-binding characteristics, including on-rate, play a pivotal role in the lytic capacity of peptide-major histocompatibility complex-targeting CAR-T cells, thus facilitating the development of strategies whereby genetically engineered CARs target intracellular antigens in cancer cells to lyse the cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenAntigens, NeoplasmHumansPeptidesImmunotherapy, AdoptiveCell Line, Tumor

Stichwörter der Autor:innen

T cellbinding affinitycancercell engineeringchimeric antigen receptorimmunotherapymajor histocompatibility complex (MHC)peptidesreceptor

Substanzen

Receptors, Chimeric AntigenAntigens, NeoplasmPeptides

Autor:innen und Institutionen

  • Department of Personalized Cancer Immunotherapy, Graduate School of Medicine, Mie University, Tsu, Mie, Japan. Electronic address: 318ds09@m.mie-u.ac.jp.
  • Department of Personalized Cancer Immunotherapy, Graduate School of Medicine, Mie University, Tsu, Mie, Japan. Electronic address: yakahori@med.mie-u.ac.jp.
  • Bio-Diagnostic Reagent Technology Center, Sysmex Corporation, Kobe, Hyogo, Japan.
  • Department of Personalized Cancer Immunotherapy, Graduate School of Medicine, Mie University, Tsu, Mie, Japan; Center for Comprehensive Cancer Immunotherapy, Mie University, Tsu, Mie, Japan.

Förderung

  • Sysmex Corp
  • Japan Science and Technology Agency

Zitieren

APA

Hiratsuka, H., Akahori, Y., Maeta, S., Egashira, Y., & Shiku, H. (2024). Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107651

Vancouver

Hiratsuka H, Akahori Y, Maeta S, Egashira Y, Shiku H. Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107651

BibTeX
@article{Hiratsuka2024,
  author = {Hiratsuka, Hiroyuki and Akahori, Yasushi and Maeta, Shingo and Egashira, Yuriko and Shiku, Hiroshi},
  title = {Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107651}
}
Kostenlos starten →